1 Min Read
Feb 23 (Reuters) - Nivalis Therapeutics Inc
* Nivalis Therapeutics announces results from phase 2 clinical trial of Cavosonstat added to Ivacaftor for treatment of cystic fibrosis Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.